ADM, adrenomedullin, 133

N. diseases: 405; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1609524
Disease: ADHF
ADHF
0.010 Biomarker disease BEFREE A phase II study with adrecizumab in patients with sepsis is ongoing and a phase II study on the effects of adrecizumab in patients with acute decompensated heart failure with elevated ADM is currently in preparation. 30592365 2019